granisetron has been researched along with Genital Neoplasms, Female in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Arai, T; Fujita, Y; Hayasaki, Y; Iihara, H; Kado, N; Mori, M; Morishige, KI; Murase, S; Nakamura, K; Sakurai, M; Shimaoka, R; Shimokawa, M; Suzuki, A; Takenaka, M; Yamamoto, S | 1 |
| Abe, M; Fujita, Y; Hayasaki, Y; Iihara, H; Matsuoka, R; Morishige, K; Nagasawa, Y; Sakurai, M; Shimokawa, M; Suzuki, A | 1 |
| Akasaka, J; Furukawa, N; Kawaguchi, R; Kobayashi, H; Nagai, A; Sasaki, Y; Shigemitsu, A | 1 |
| Fujiwara, S; Kanemura, M; Ohmichi, M; Sasaki, H; Terai, Y; Tsunetoh, S | 1 |
| Regidor, PA; Schindler, AE | 1 |
| Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 2 |
| Barbieri, P; Boccardo, E; Carnino, F; Danese, S; Ferraris, C; Giardina, G; Guercio, E; Inganni, P; Lissoni, A; Maggi, R; Richiardi, G; Sismondi, P | 1 |
| Akutagawa, N; Fukunaka, N; Hayashi, T; Kitajima, Y; Kudo, R; Mizumoto, H; Nakamura, T; Sagae, S; Sugimura, M; Terasawa, K; Wataba, K; Yamana, K | 1 |
| Lehoczky, O | 1 |
| Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K | 1 |
| Bagaméri, A; Kulcsár, T; Lehoczky, O; Pulay, T; Sárosi, Z | 1 |
| Kulp, B; Markman, M; Markman, MR; Peterson, G | 1 |
9 trial(s) available for granisetron and Genital Neoplasms, Female
| Article | Year |
|---|---|
Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study.
Topics: Adult; Aged; Antiemetics; Aprepitant; Carboplatin; Dexamethasone; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Olanzapine; Vomiting | 2020 |
Study protocol for an open-label, single-arm, multicentre phase II trial to evaluate the efficacy and safety of combined triplet therapy and olanzapine for prevention of carboplatin-induced nausea and vomiting in gynaecological cancer patients.
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Carboplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Olanzapine; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting | 2019 |
Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Cross-Over Studies; Diet; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Isoquinolines; Middle Aged; Morpholines; Nausea; Paclitaxel; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2015 |
Control of carboplatin-induced emesis with a fixed low dose of granisetron (0.5 mg) plus dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Dexamethasone; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Treatment Outcome; Vomiting | 1996 |
Antiemetic efficacy of granisetron in patients with gynecological malignancies.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Single-Blind Method; Treatment Outcome; Vomiting | 1997 |
[A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1997 |
Low-dose oral granisetron (1 mg) plus intravenous dexamethasone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Dexamethasone; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Injections, Intravenous; Middle Aged; Treatment Outcome; Vomiting | 1998 |
Report on the antiemetic effectivity of a single 1 mg oral granisetron in moderately emetogenic chemotherapies of gynecological malignancies.
Topics: Administration, Oral; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Patient Satisfaction; Prospective Studies; Treatment Outcome; Vomiting | 1998 |
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting | 2000 |
4 other study(ies) available for granisetron and Genital Neoplasms, Female
| Article | Year |
|---|---|
Evaluation of the relation between patient characteristics and the state of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving paclitaxel and carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Dexamethasone; Female; Genital Neoplasms, Female; Granisetron; Humans; Hyperemesis Gravidarum; Hypertension; Middle Aged; Multivariate Analysis; Nausea; Paclitaxel; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Vomiting | 2014 |
[Granisetron, a new and potent antiemetic for treatment of cytostatic drug-induced vomiting in gynecological malignancies].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Vomiting | 1994 |
[Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
Topics: Alprazolam; Anti-Anxiety Agents; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diazepam; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Meprobamate; Middle Aged; Treatment Outcome; Vomiting | 2001 |
Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Clinical Trials as Topic; Dexamethasone; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Serotonin Antagonists; Taxoids; Vomiting | 2002 |